Molecular Templates, Inc. (MTEM): Price and Financial Metrics


Molecular Templates, Inc. (MTEM)

Today's Latest Price: $8.25 USD

0.49 (-5.61%)

Updated Nov 13 9:30am

Add MTEM to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

MTEM Stock Summary

  • MTEM's price/sales ratio is 12.97; that's higher than the P/S ratio of 92.12% of US stocks.
  • With a year-over-year growth in debt of 349.95%, Molecular Templates Inc's debt growth rate surpasses 94.71% of about US stocks.
  • Revenue growth over the past 12 months for Molecular Templates Inc comes in at 620.26%, a number that bests 98.91% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to MTEM, based on their financial statements, market capitalization, and price volatility, are CANF, VBIV, LJPC, GLMD, and BLCM.
  • MTEM's SEC filings can be seen here. And to visit Molecular Templates Inc's official web site, go to www.mtem.com.
MTEM Daily Price Range
MTEM 52-Week Price Range

MTEM Stock Price Chart More Charts


MTEM Price/Volume Stats

Current price $8.25
Prev. close $9.22
Day low $8.25
Day high $8.34
50-day MA $7.20
200-day MA $6.57
52-week high $9.77
52-week low $3.19
Volume 6,001
Avg. volume 101,240
Dividend yield N/A
Market Cap 304.73M

Molecular Templates, Inc. (MTEM) Company Bio


Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is based in Austin, Texas.





MTEM Latest News Stream


Event/Time News Detail
Loading, please wait...

MTEM Latest Social Stream


Loading social stream, please wait...

View Full MTEM Social Stream

MTEM Price Returns

1-mo 23.50%
3-mo 64.02%
6-mo 10.44%
1-year 80.53%
3-year 41.51%
5-year -73.87%
YTD 104.21%
2018 -59.68%
2017 107.02%
2016 -8.33%
2015 -84.91%
2014 -31.91%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7822 seconds.